GSK PLC 2022 AR2
The report highlights a landmark year for GSK, marked by the successful demerger of its consumer healthcare business to form Haleon, establishing GSK as a fully focused biopharma company. In 2022, the company delivered strong financial performance with a 13% CER turnover growth to #29.3 billion, driven by its Vaccines and Specialty Medicines portfolios. Key clinical milestones included positive phase III results for its RSV older adult vaccine candidate and gepotidacin for uncomplicated urinary tract infections. On the sustainability front, GSK maintained its first-place ranking in the Access to Medicine Index for the eighth consecutive time and achieved a 13% reduction in its Scope 3 carbon emissions compared to 2020.
Company: GSK PLC
Sector: Manufacturing
Country: United Kingdom
Year: 2022
Type: AR2
Pages: 320
Back to company
GSK PLC
Annual Report
The report highlights a landmark year for GSK, marked by the successful demerger of its consumer healthcare business to form Haleon, establishing GSK as a fully focused biopharma company. In 2022, the company delivered strong financial performance with a 13% CER turnover growth to #29.3 billion, driven by its Vaccines and Specialty Medicines portfolios. Key clinical milestones included positive phase III results for its RSV older adult vaccine candidate and gepotidacin for uncomplicated urinary tract infections. On the sustainability front, GSK maintained its first-place ranking in the Access to Medicine Index for the eighth consecutive time and achieved a 13% reduction in its Scope 3 carbon emissions compared to 2020.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Net Zero Target
Employees